The success rate was 32/46 (70%). All patients had T3 and T4 stage disease with Gleason scores >8. In conclusion, orchidectomy combined with EBRT was found to be an effective and feasible option for relieving BOO due to prostate cancer....
Combinational therapy approaches hold promise for surpassing conventional treatments. They offer the potential for more precise targeting of cancer cells and a greater success rate due to the enhanced effectiveness of radiosensitizing agents. A radiosensitizer agent is a substance with a high-Z element...
Nanoparticles for enhanced radiotherapy Mechanisms underlying radiotherapy sensitization Nanoparticle-based treatments synergize with radiotherapy for cancer therapy Nanoparticle-based radioenhancer in clinical practice Conclusions and outlooks Acknowledgments Author contributions Declaration of interests ReferencesShow full...
We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...
However, this might be interpreted by the fact that patients with such low PSA values and only local uptake in PET have a very low risk for distant metastatic disease. Thus, it is very likely that the recurrent prostate cancer in this patient group is cured by sRT to the prostatic fossa....
Radiotherapy is one of the most common countermeasures for treating a wide range of tumors. However, the radioresistance of cancer cells is still a major limitation for radiotherapy applications. Efforts are continuously ongoing to explore sensitizing ta
to efficiently treat eight to 10 patients on Unity each day. Since the center went clinical with Unity two years ago, it has treated 283 patients, including those with prostate cancer (full-course or hypofractioned) and patients needing boost treatments for anal, rectal or breast cancer. ...
Matthew Price:We’ve completed the treatment sites for prostate and pelvis. Our teams are much more comfortable using Monaco now and our process for building templates is far easier due to better understanding of the Monaco solution, in addition to experience – where synergy exists between sites...
Radiotherapy is a non-invasive standard treatment for prostate cancer (PC). However, PC develops radio-resistance, highlighting a need for agents to improve radiotherapy response. Canagliflozin, an inhibitor of sodium-glucose co-transporter-2, is approve
Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies ...